StockData
Attovia Therapeutics, Inc. logo

Attovia Therapeutics, Inc. (ATTO) stock

ATTONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026
$14.86+0.13 (+0.92%)

Close on Nov 17, 2026Market cap $678.38MP/E –Yield –

Attovia Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Attovia Therapeutics

Attovia Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Attovia Therapeutics figures

See a number that looks wrong?